STRIDES PHARMA SCIENCE
Quarterly Results Analysis [Mar2025]
STRIDES PHARMA SCIENCE Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,190 Cr | ₹1,154 Cr | ₹1,201 Cr | ₹1,088 Cr | ₹1,044 Cr | ₹1,006 Cr | ₹999 Cr | ₹930 Cr |
Expenses | ₹973 Cr | ₹943 Cr | ₹965 Cr | ₹871 Cr | ₹839 Cr | ₹864 Cr | ₹846 Cr | ₹763 Cr |
Operating Income | ₹218 Cr | ₹210 Cr | ₹236 Cr | ₹217 Cr | ₹204 Cr | ₹142 Cr | ₹153 Cr | ₹167 Cr |
Other Income | ₹12 Cr | ₹6 Cr | ₹28 Cr | ₹13 Cr | ₹-14 Cr | ₹9 Cr | ₹36 Cr | ₹9 Cr |
Interest | ₹50 Cr | ₹52 Cr | ₹82 Cr | ₹80 Cr | ₹71 Cr | ₹70 Cr | ₹79 Cr | ₹76 Cr |
Depreciation | ₹49 Cr | ₹48 Cr | ₹51 Cr | ₹49 Cr | ₹48 Cr | ₹49 Cr | ₹60 Cr | ₹60 Cr |
Profit Before Tax | ₹103 Cr | ₹113 Cr | ₹128 Cr | ₹97 Cr | ₹64 Cr | ₹22 Cr | ₹-115 Cr | ₹33 Cr |
Profit After Tax | ₹82 Cr | ₹89 Cr | ₹106 Cr | ₹80 Cr | ₹51 Cr | ₹6 Cr | ₹-107 Cr | ₹24 Cr |
EPS | ₹8.92 | ₹9.54 | ₹10.14 | ₹7.64 | ₹1.98 | ₹5.41 | ₹-14.54 | ₹-0.77 |
Industry Peers & Returns | 1W | 1M | 1Y |
STRIDES PHARMA SCIENCE | 8.6% | 34.7% | -4.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | -2.9% | 12.6% |
DIVIS LABORATORIES | 0.3% | 6.5% | 49% |
CIPLA | 1.1% | 1.8% | -1.6% |
TORRENT PHARMACEUTICALS | 1.9% | 0.4% | 14% |
DR REDDYS LABORATORIES | -0.2% | 9.5% | 12.8% |
MANKIND PHARMA | -0.4% | -7.8% | 9.9% |
ZYDUS LIFESCIENCES | -0.8% | 7.9% | -10.1% |
LUPIN | 0.2% | -2.8% | 23.9% |
STRIDES PHARMA SCIENCE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 3.18 % |
Y-o-Y | 14.08 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,190 Cr | 3.18 | |
Dec2024 | ₹1,154 Cr | -3.95 | |
Sep2024 | ₹1,201 Cr | 10.45 | |
Jun2024 | ₹1,088 Cr | 4.22 | |
Mar2024 | ₹1,044 Cr | 3.75 | |
Dec2023 | ₹1,006 Cr | 0.63 | |
Sep2023 | ₹999 Cr | 7.47 | |
Jun2023 | ₹930 Cr | - |
STRIDES PHARMA SCIENCE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 3.59 % |
Y-o-Y | 6.63 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹218 Cr | 3.59 | |
Dec2024 | ₹210 Cr | -10.81 | |
Sep2024 | ₹236 Cr | 8.68 | |
Jun2024 | ₹217 Cr | 6.20 | |
Mar2024 | ₹204 Cr | 43.89 | |
Dec2023 | ₹142 Cr | -7.27 | |
Sep2023 | ₹153 Cr | -8.08 | |
Jun2023 | ₹167 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.38 % |
Y-o-Y | -6.54 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 18.3% | 0.38 | |
Dec2024 | 18.23% | -7.13 | |
Sep2024 | 19.63% | -1.60 | |
Jun2024 | 19.95% | 1.89 | |
Mar2024 | 19.58% | 38.67 | |
Dec2023 | 14.12% | -7.83 | |
Sep2023 | 15.32% | -14.46 | |
Jun2023 | 17.91% | - |
STRIDES PHARMA SCIENCE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -7.41 % |
Y-o-Y | 61.30 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹82 Cr | -7.41 | |
Dec2024 | ₹89 Cr | -16.33 | |
Sep2024 | ₹106 Cr | 32.89 | |
Jun2024 | ₹80 Cr | 56.66 | |
Mar2024 | ₹51 Cr | 784.93 | |
Dec2023 | ₹6 Cr | Positive | |
Sep2023 | ₹-107 Cr | Negative | |
Jun2023 | ₹24 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -10.23 % |
Y-o-Y | 41.43 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.93 % | -10.23 | |
Dec2024 | 7.72 % | -12.87 | |
Sep2024 | 8.86 % | 20.22 | |
Jun2024 | 7.37 % | 50.41 | |
Mar2024 | 4.9 % | 759.65 | |
Dec2023 | 0.57 % | Positive | |
Sep2023 | -10.73 % | Negative | |
Jun2023 | 2.53 % | - |
STRIDES PHARMA SCIENCE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -6.50 % |
Y-o-Y | 350.51 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹8.92 | -6.50 | |
Dec2024 | ₹9.54 | -5.92 | |
Sep2024 | ₹10.14 | 32.72 | |
Jun2024 | ₹7.64 | 285.86 | |
Mar2024 | ₹1.98 | -63.40 | |
Dec2023 | ₹5.41 | Positive | |
Sep2023 | ₹-14.54 | Negative | |
Jun2023 | ₹-0.77 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD